135 related articles for article (PubMed ID: 37855250)
1. Multimodal Nanoplatform with ROS Amplification to Overcome Multidrug Resistance in Prostate Cancer via Targeting P-Glycoprotein and Ferroptosis.
Guan Y; Lei H; Xing C; Yan B; Lin B; Yang X; Huang H; Kang Y; Pang J
Adv Healthc Mater; 2024 Jan; 13(3):e2301345. PubMed ID: 37855250
[TBL] [Abstract][Full Text] [Related]
2. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles.
Lu Q; Gao W; Chen Z; Liu Z; Wang J; Zeng L; Hu X; Zheng E; Zhang Q; Song H
Int J Pharm; 2024 Apr; 655():124028. PubMed ID: 38518871
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
5. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
Chang N; Zhao Y; Ge N; Qian L
Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
[TBL] [Abstract][Full Text] [Related]
6. Nanocracker capable of simultaneously reversing both P-glycoprotein and tumor microenvironment.
Lee T; Kim KS; Na K
J Control Release; 2023 Feb; 354():268-278. PubMed ID: 36634708
[TBL] [Abstract][Full Text] [Related]
7. An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
Wu ZL; Chen Y; Qu Z; Wu GY; He XF; Huang JW; Meng QQ; Hu YH; Shen XL; Yang RY; Hu YJ
J Ethnopharmacol; 2022 Aug; 294():115353. PubMed ID: 35533911
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide reverses drug resistance by inhibiting ATPase activity of p-glycoprotein in human multi-drug resistant cancer cells.
Sinha BK; Bortner CD; Mason RP; Cannon RE
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2806-2814. PubMed ID: 30251669
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.
Zhang J; Wang L; Fai Chan H; Xie W; Chen S; He C; Wang Y; Chen M
Sci Rep; 2017 May; 7():46057. PubMed ID: 28470171
[TBL] [Abstract][Full Text] [Related]
10. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
[TBL] [Abstract][Full Text] [Related]
11. A hyaluronic acid modified cuprous metal-organic complex for reversing multidrug resistance via redox dyshomeostasis.
Wan Y; Chen Z; Wang Y; Zhao W; Pei Z; Pu L; Lv Y; Li J; Li J; Pei Y
Carbohydr Polym; 2023 Jul; 311():120762. PubMed ID: 37028879
[TBL] [Abstract][Full Text] [Related]
12. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes.
Patel NR; Rathi A; Mongayt D; Torchilin VP
Int J Pharm; 2011 Sep; 416(1):296-9. PubMed ID: 21703341
[TBL] [Abstract][Full Text] [Related]
14. Multi-Enzyme Cascade-Triggered Nitric Oxide Release Nanoplatform Combined with Chemo Starvation-like Therapy for Multidrug-Resistant Cancers.
Li G; Lu X; Zhang S; Zhang J; Fu X; Zhang M; Teng L; Sun F
ACS Appl Mater Interfaces; 2023 Jul; 15(26):31285-31299. PubMed ID: 37344958
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer.
Shi X; Yang X; Liu M; Wang R; Qiu N; Liu Y; Yang H; Ji J; Zhai G
Carbohydr Polym; 2021 Feb; 254():117459. PubMed ID: 33357918
[TBL] [Abstract][Full Text] [Related]
16. Mosloflavone from Fissistigma petelotii ameliorates oncogenic multidrug resistance by STAT3 signaling modulation and P-glycoprotein blockade.
Chien PY; Lan YH; Wu IT; Huang YP; Hung CC
Phytomedicine; 2024 Jan; 123():155210. PubMed ID: 38006807
[TBL] [Abstract][Full Text] [Related]
17. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
[TBL] [Abstract][Full Text] [Related]
18. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
19. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics analysis of multidrug resistance in colorectal cancer cell and multidrug resistance reversal effect of verapamil.
Wang X; Wang Z; Wang K; Gao M; Zhang H; Xu X
Biomed Chromatogr; 2021 Feb; 35(2):e4976. PubMed ID: 32852057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]